Liver stiffness and severe fibrosis, as measured by FibroScan, are independently linked to type 2 diabetes (T2DM) in patients with metabolic dysfunction-associated steatotic liver disease (MASLD), new ...

A new cross-sectional study published in the journal of Arthritis Care & Research revealed that symptomatic knee ...

—Review the data and clinical implications when comparing early-onset type 2 diabetes in to early-onset type 1 diabetes. Reviewed by Clifton Jackness, MD, Attending Physician in Endocrinology, Lenox ...

Researchers in China evaluated 432 patients with HeFH, including 99 with T2DM and 333 without, for prevalence and severity of CAD. Patients in the T2DM group had a greater number of diseased arteries ...

Investigators assessed the predictive value of estimated glucose disposal rate on renal outcomes among patients with type 2 diabetes mellitus. Rapid eGFR decline was found to be associated with an ...

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by progressive hyperglycaemia secondary to declining β-cell function, and usually accompanied by a reduced sensitivity to ...

High consumption of red meat is associated with an increased risk of type 2 diabetes mellitus, but the causality of the association is difficult to prove. Nevertheless, the findings of a large study ...

Polyneuropathy occurs when multiple peripheral nerves malfunction throughout the body. Neuropathy is a common complication of type 2 diabetes mellitus (T2DM). Polyneuropathy occurs when there is ...

Targeting glucose control and managing cardiovascular (CV) risk factors may prevent future CV events, and have positive downstream impact by reducing costs to healthcare stakeholders.

Strategies that can help clinicians establish and work toward goals when treating patients with chronic kidney disease to help control disease and prevent progression. Neil B. Minkoff, MD: We’ve ...

The burden of T2DM is increasing worldwide, with enormous implications for morbidity and mortality. Early and effective ...

Data from the ONWARDS clinical trial program supported the efficacy of once-weekly insulin icodec-abae compared with daily basal insulin. The Food and Drug Administration (FDA) has approved Awiqli ® ...